---
figid: PMC9358267__jdapm-22-277-g004
pmcid: PMC9358267
image_filename: jdapm-22-277-g004.jpg
figure_link: /pmc/articles/PMC9358267/figure/F4/
number: Fig. 4
figure_title: 'Phosphorylation of p38 following co-treatment of WISH cells with DEX
  and LPS was evaluated using western blot analysis. Relative amounts of phospho-p38
  protein were analyzed in triplicate experiments and normalized to that of p38. #P
  < 0.05 versus control group; *P < 0.05 versus LPS group. DEX, dexmedetomidine; LPS,
  lipopolysaccharide'
caption: 'Phosphorylation of p38 following co-treatment of WISH cells with DEX and
  LPS was evaluated using western blot analysis. Relative amounts of phospho-p38 protein
  were analyzed in triplicate experiments and normalized to that of p38. #P < 0.05
  versus control group; *P < 0.05 versus LPS group. DEX, dexmedetomidine; LPS, lipopolysaccharide.'
article_title: Dexmedetomidine and LPS co-treatment attenuates inflammatory response
  on WISH cells via inhibition of p38/NF-ÎºB signaling pathway.
citation: Tae-Sung Kim, et al. J Dent Anesth Pain Med. 2022 Aug;22(4):277-287.
year: '2022'

doi: 10.17245/jdapm.2022.22.4.277
journal_title: Journal of Dental Anesthesia and Pain Medicine
journal_nlm_ta: J Dent Anesth Pain Med
publisher_name: The Korean Dental Society of Anesthsiology

keywords:
- Cyclooxygenase 2 Inhibitors
- Dexmedetomidine
- Lipopolysaccharides
- Prostaglandin E2
- WISH Cells

---
